Merck KGaA (GB:0O14)

Merck KGaA (0O14) Stock Price & Analysis


0O14 Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€151.00 - €199.52
Previous Close€165.04
Average Volume (3M)211.69K
Market Cap
Enterprise Value€80.64B
Total Cash (Recent Filing)€1.64B
Total Debt (Recent Filing)€10.40B
Price to Earnings (P/E)22.1
Aug 03, 2023
2.36 (1.43%)
Share Statistics
EPS (TTM)7.45
Shares Outstanding434,777,877
10 Day Avg. Volume43,595
30 Day Avg. Volume211,687
Standard Deviation0.06
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside24.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11



0O14 FAQ

What was Merck KGaA’s price range in the past 12 months?
Merck KGaA lowest stock price was €151.00 and its highest was €199.52 in the past 12 months.
    What is Merck KGaA’s market cap?
    Currently, no data Available
    When is Merck KGaA’s upcoming earnings report date?
    Merck KGaA’s upcoming earnings report date is Aug 03, 2023 which is in 66 days.
      How were Merck KGaA’s earnings last quarter?
      Merck KGaA released its earnings results on May 11, 2023. The company reported €2.36 earnings per share for the quarter, beating the consensus estimate of €2.305 by €0.055.
        Is Merck KGaA overvalued?
        According to Wall Street analysts Merck KGaA’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Merck KGaA pay dividends?
          Merck KGaA pays a Annually dividend of €2.2 which represents an annual dividend yield of 1.12%. See more information on Merck KGaA dividends here
            What is Merck KGaA’s EPS estimate?
            Merck KGaA’s EPS estimate is €2.43.
              How many shares outstanding does Merck KGaA have?
              Merck KGaA has 129,242,250 shares outstanding.
                What happened to Merck KGaA’s price movement after its last earnings report?
                Merck KGaA reported an EPS of €2.36 in its last earnings report, beating expectations of €2.305. Following the earnings report the stock price went up 1.619%.
                  Which hedge fund is a major shareholder of Merck KGaA?
                  Currently, no hedge funds are holding shares in GB:0O14


                  Merck KGaA Stock Smart Score

                  The Merck KGaA Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Merck KGaA

                  Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. In its performance materials segment, the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Dermapharm Holding SE
                  ATAI Life Sciences
                  PharmaSGP Holding SE
                  APONTIS PHARMA AG
                  MPH Health Care AG

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis